SuperworthPro DEX profit margin PDEX
Gross, operating and net profit as a share of revenue over the last twelve months, from 2011.
- Net margin, 12 months
- 17.6%
- Operating margin, 12 months
- 16.8%
- Net margin on a year earlier
- +4.1 pts
- Peer median
- 6.9%
Over the twelve months to Jun 30, 2026, Pro DEX kept 17.6% of its revenue as net profit, with an operating margin of 16.8% and a gross margin of 31.4%.
Five years earlier its net margin was 16.2%.
The median for 10 medical instruments and supplies stocks of a similar size is 6.9%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2026 | 17.6% | 16.8% | 31.4% |
| FY2025 | 13.5% | 16.1% | 29.3% |
| FY2024 | 4.0% | 13.3% | 27.0% |
| FY2023 | 15.3% | 12.5% | 27.7% |
| FY2022 | 10.9% | 12.2% | 31.2% |
| FY2021 | 16.2% | 11.9% | 35.7% |
| FY2020 | 17.5% | 20.3% | 37.7% |
| FY2019 | 15.3% | 18.4% | 36.0% |
| FY2018 | 7.2% | 10.6% | 35.4% |
| FY2017 | 23.2% | 12.5% | 32.8% |
| FY2016 | 4.2% | 3.9% | 26.0% |
| FY2015 | −2.7% | −6.7% | 27.7% |
| FY2014 | −4.5% | −7.5% | 27.4% |
| FY2013 | −14.6% | −15.5% | 30.3% |
| FY2012 | −5.1% | −7.9% | 31.4% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q4 FY26 | 17.6% | +4.1 pts | 16.8% | |
| Q3 FY26 | 16.1% | +1.5 pts | 14.5% | |
| Q2 FY26 | 15.7% | +4.7 pts | 15.7% | |
| Q1 FY26 | 15.9% | +6.8 pts | 15.4% | |
| Q4 FY25 | 13.5% | +9.5 pts | 16.1% | |
| Q3 FY25 | 14.6% | +10.5 pts | 18.2% | |
| Q2 FY25 | 11.1% | +4.8 pts | 16.8% | |
| Q1 FY25 | 9.2% | −2.0 pts | 14.7% | |
| Q4 FY24 | 4.0% | −11.4 pts | 13.3% | |
| Q3 FY24 | 4.1% | −11.3 pts | 13.0% | |
| Q2 FY24 | 6.2% | −8.2 pts | 13.0% | |
| Q1 FY24 | 11.2% | +0.3 pts | 14.2% |
Against its peers
Companies in Medical - Instruments & Supplies nearest Pro DEX's size, closest first, today.
| Company | Profit margin |
|---|---|
| PDEXPro DEX | 17.6% |
| UTMDUtah Medical Products | 29.0% |
| INFUInfuSystem | 6.0% |
| EMBCEmbecta | 8.6% |
| KEQUKewaunee Scientific | 3.0% |
| TCMDTactile Systems Technology | 7.1% |
| MDXGMimedx | 1.8% |
| APTAlpha Pro Tech | 6.8% |
| MOVMovado | 6.0% |
| NEPHNephros | 8.4% |
| IRMDIradimed | 26.7% |
| Peer median | 6.9% |
Where Pro DEX ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Pro DEX
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.